|
Post by brentie on Aug 2, 2022 6:01:11 GMT -5
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM (Eastern Time) on Tuesday, August 9, 2022. Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at mannkindcorp.com/news-events/ under Events. investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2022-second-quarter-financial-results
|
|
|
Post by georgethenight2 on Aug 2, 2022 8:28:20 GMT -5
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM (Eastern Time) on Tuesday, August 9, 2022. Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at mannkindcorp.com/news-events/ under Events. investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2022-second-quarter-financial-resultsPersonally, most anticipated quarterly in years. Come on MC. Show me the money!!!
|
|
|
Post by akemp3000 on Aug 2, 2022 9:59:50 GMT -5
UTHR reports on Aug 3 before the opening. Here's one encouraging excerpt: "In May, United Therapeutics received FDA approval for Tyvaso Dry Powder Inhaler (DPI) (Treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). This is expected to have benefitted Tyvaso sales in the to-be-reported quarter, which is already recording strong sales growth, driven by patient growth. The Zacks Consensus Estimate for total Tyvaso sales is currently pegged at $184 million".
Hopefully this is accurate and a precursor to the upcoming MNKD call.
|
|
|
Post by rayskum on Aug 2, 2022 10:18:03 GMT -5
UTHR reports on Aug 3 before the opening. Here's one encouraging excerpt: "In May, United Therapeutics received FDA approval for Tyvaso Dry Powder Inhaler (DPI) (Treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). This is expected to have benefitted Tyvaso sales in the to-be-reported quarter, which is already recording strong sales growth, driven by patient growth. The Zacks Consensus Estimate for total Tyvaso sales is currently pegged at $184 million". Hopefully this is accurate and a precursor to the upcoming MNKD call. Akemp- I hope you are correct. But we didn’t see any sales for Tyvaso DPI in symphony data, correct? I wonder why. Thoughts?
|
|
|
Post by mango on Aug 2, 2022 11:11:21 GMT -5
A top MannKind regional sales guy has disclosed that this is MannKind’s best quarter ever. Get ready for earnings, ya’ll
|
|
|
Post by akemp3000 on Aug 2, 2022 11:27:51 GMT -5
UTHR reports on Aug 3 before the opening. Here's one encouraging excerpt: "In May, United Therapeutics received FDA approval for Tyvaso Dry Powder Inhaler (DPI) (Treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). This is expected to have benefitted Tyvaso sales in the to-be-reported quarter, which is already recording strong sales growth, driven by patient growth. The Zacks Consensus Estimate for total Tyvaso sales is currently pegged at $184 million". Hopefully this is accurate and a precursor to the upcoming MNKD call. Akemp- I hope you are correct. But we didn’t see any sales for Tyvaso DPI in symphony data, correct? I wonder why. Thoughts? I honestly don't have a clue. I simply pasted something I came across and thought it worth sharing. I'm hopeful the UTHR report tomorrow morning will be good followed by Mannkind's report next Tuesday that I hope to be even better. Regardless of what happens now, IMO, good news and reporting for this company is going to happen sooner rather than later. If not Q2, then Q3. I've waited years. I can now wait weeks if necessary
|
|
|
Post by uvula on Aug 2, 2022 11:28:18 GMT -5
This is a reply to mango's post:
Good news of course, but grumpy uvula is pretty sure that the sales rep is either guessing or broke his agreement to not disclose confidential information. Either way it was stupid to post that. And I'm sure his management is not pleased.
|
|
|
Post by akemp3000 on Aug 2, 2022 11:33:13 GMT -5
This is a reply to mango's post: Good news of course, but grumpy uvula is pretty sure that the sales rep is either guessing or broke his agreement to not disclose confidential information. Either way it was stupid to post that. And I'm sure his management is not pleased. Unless it's true
|
|
|
Post by dh4mizzou on Aug 2, 2022 11:48:35 GMT -5
So IF UTHR reports better than expected numbers for Tyvaso what are the chances we continue this climb up to the MNKD ER?
|
|
|
Post by awesomo on Aug 2, 2022 11:56:58 GMT -5
Mango’s post just shows the rampant narcissism of LinkedIn…
|
|
|
Post by nylefty on Aug 2, 2022 13:01:54 GMT -5
Mango’s post just shows the rampant narcissism of LinkedIn… And the sales guy didn't say it was the "best" quarter. He said it was " one" of the best.
|
|
|
Post by mango on Aug 2, 2022 13:02:18 GMT -5
Mango’s post just shows the rampant narcissism of LinkedIn… Can you please point out the examples of narcissistic behavior demonstrated by the MannKind employee? Because I see the total opposite. The guy only congratulates his team, MannKind and gave full credit to some other dude for leading the way. I don’t see a single narcissistic comment. You are always negative and put a negative spin on everything so doesn’t surprise be the least you would make something up like that. lol
|
|
|
Post by awesomo on Aug 2, 2022 18:17:46 GMT -5
Mango’s post just shows the rampant narcissism of LinkedIn… Can you please point out the examples of narcissistic behavior demonstrated by the MannKind employee? Because I see the total opposite. The guy only congratulates his team, MannKind and gave full credit to some other dude for leading the way. I don’t see a single narcissistic comment. You are always negative and put a negative spin on everything so doesn’t surprise be the least you would make something up like that. lol It's called a "humblebrag" and it is all over LinkedIn. It's fake modesty to boast about his accomplishments. Absolute generic boilerplate "look at how good my team is", "no egos here", "teamwork valued over all", "leadership first". Sorry you can't see through it.
|
|
|
Post by sportsrancho on Aug 2, 2022 18:47:41 GMT -5
This is a reply to mango's post: Good news of course, but grumpy uvula is pretty sure that the sales rep is either guessing or broke his agreement to not disclose confidential information. Either way it was stupid to post that. And I'm sure his management is not pleased. I’m the one that found that on LinkedIn, and I don’t think he’s guessing:-) he’s just happy about it. Does he know he’s not supposed to say that.. probably not, I kind of thought it was a find:-)
|
|
|
Post by sportsrancho on Aug 2, 2022 18:50:27 GMT -5
But I will add if it’s fake to boost his accomplishments. Not good at all. Awesomo may be right🤷♀️
|
|